Evaluate the Effect of Dry Needling on the Temporomandibular Joint in Subjects Who Have Suffered a Whiplash as a Result of a Traffic Accident

Randomized, Open Clinical Trial to Evaluate the Effect of Dry Needling on the Temporomandibular Joint in Subjects Who Have Suffered a Whiplash as a Result of a Traffic Accident

The transportation industry is growing rapidly and the most popular mode is overland by road. Traffic accidents are the most direct and serious risk to the lives of Western people. A large number of traffic accidents occur on the roads each year, especially those caused by motor vehicles on motorways and urban ring roads, often resulting in massive loss of life. According to the World Health Organization (WHO), 1.35 million people die each year worldwide.

Whiplash is the most common injury in motor vehicle collisions, affecting 83% of injured people.

The temporomandibular joint (TMJ) is one of the most complex joints in the human body, since in addition to performing functions in dental occlusion, it does so in the neuromuscular system.

Due to the relationship of the neck with the mandible, the main objective of the study is to determine if there is an improvement in pain and functional limitation in general by applying the dry needling technique in the temporomandibular joint musculature.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having suffered a traffic accident
  • Having suffered a subsequent collision
  • Having been diagnosed with whiplash in the hospital ''Fundación Jiménez Díaz (FJD)´´ emergency room in the first 72 hours after the collision.
  • Age between 18-45 years, to avoid osteoarthritis and other degenerative problems.
  • Minimum 3 in temporomandibular joint (TMJ) according to Visual Analog Scale (VAS)
  • Consent to participate

Exclusion Criteria:

  • Temporomandibular joint (TMJ) or craniofacial surgeries
  • Spinal surgery
  • Direct trauma in temporomandibular joint (TMJ) or prior to the accident
  • Botox, silicones or any type of cosmetic surgery in the facial region.
  • Problems of migraines and tension headaches (pre-accident)
  • Any degenerative musculoskeletal disease (fibromyalgia, rheumatoid arthritis, osteoarthritis)
  • Fear of needles
  • Any neurological disorder (trigeminal neuralgia, epilepsy)
  • Pregnancy
  • Uncontrolled vascular or metabolic problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: dry needle
It is a minimally invasive treatment modality. Its effectiveness has been confirmed in numerous studies. It consists of applying an antiseptic in the puncture area and inserting the needle in the required aseptic conditions. During puncture, the patient's physical response is observed at all times, in order to control the local spasmodic responses in each muscle. After applying the technique, we assessed jaw pain, mouth opening, and the appearance of headaches. The adverse effects of the technique are the following: pain after puncture (1.7%), local bleeding at the puncture site (6.1%) and syncopal responses (0.7%).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Visit 1 (First day of treatment)
Years (Demographic variables)
Visit 1 (First day of treatment)
Gender
Time Frame: Visit 1 (First day of treatment)
Male, Female, Does not answer (Demographic variables)
Visit 1 (First day of treatment)
Weight
Time Frame: Visit 1 (First day of treatment)
Kilograms (Demographic variables)
Visit 1 (First day of treatment)
Height
Time Frame: Visit 1 (First day of treatment)
Meters (Demographic variables)
Visit 1 (First day of treatment)
Mouth opening
Time Frame: Visit 1(First day of treatment) and Visit 2 (One week after visit 1)
Millimeters (Basal conditions)
Visit 1(First day of treatment) and Visit 2 (One week after visit 1)
Jaw pain
Time Frame: Visit 1(First day of treatment) and Visit 2 (One week after visit 1)
Visual Analog Scale (VAS) 1-10 (Basal conditions)
Visit 1(First day of treatment) and Visit 2 (One week after visit 1)
Headache
Time Frame: Visit 1(First day of treatment) and Visit 2 (One week after visit 1)
Visual Analog Scale (VAS) 1-10 (Basal conditions)
Visit 1(First day of treatment) and Visit 2 (One week after visit 1)
Joint clicking
Time Frame: Visit 1(First day of treatment) and Visit 2 (One week after visit 1)
Yes/No (Basal conditions)
Visit 1(First day of treatment) and Visit 2 (One week after visit 1)
Pressure masseter, pterygoid, and temporalis
Time Frame: Visit 1 (First day of treatment)
Determine pressure in kg in the masseter, temporal, and pterygoid muscles with an algometer to obtain 5/10 in Visual Analog Scale (VAS) to all participants
Visit 1 (First day of treatment)
Pain masseter, pterygoid, and temporalis
Time Frame: Visit 1(First day of treatment) and Visit 2 (One week after visit 1)
Obtain pain from 1 to 10 in the masseter, temporal, and pterygoid muscles according to the Visual Analog Scale (VAS) after applying the pressure obtained with the algometer in the previous step. *Patients in the experimental group are evaluated 10 minutes after the application of dry needling
Visit 1(First day of treatment) and Visit 2 (One week after visit 1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2023

Primary Completion (Estimated)

January 29, 2024

Study Completion (Estimated)

May 30, 2024

Study Registration Dates

First Submitted

August 17, 2023

First Submitted That Met QC Criteria

August 28, 2023

First Posted (Actual)

September 5, 2023

Study Record Updates

Last Update Posted (Actual)

October 3, 2023

Last Update Submitted That Met QC Criteria

October 2, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Whiplash

Clinical Trials on Dry needling

3
Subscribe